Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-12

Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and immunogenicity of simultaneous administration of EV71 vaccine and influenza vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EV71 vaccine (enterovirus 71 vaccine)
  • Influenza vaccine (influenza vaccine)

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Enterovirus Infections, Influenza | Phase 4 | Status: COMPLETED